Strategy and holdings
SPWO tracks the S&P DM Ex-U.S. & EM 50/50 Shariah Index (DM and EM standing for developed markets and emerging markets), which blends developed-market-ex-US and emerging-market Shariah-screened companies in roughly equal halves rather than weighting purely by market capitalization, which would otherwise skew the fund toward developed markets. This produces meaningfully more emerging-market exposure than a typical market-cap-weighted international index. Taiwan Semiconductor Manufacturing is the single largest holding at nearly 20% of the fund, reflecting both the size of the underlying index constituent and the general Shariah-friendliness of asset-light or low-debt technology manufacturers. Samsung Electronics, SK Hynix, and MediaTek add further semiconductor and electronics weighting, while Alibaba represents Chinese e-commerce exposure and Roche, Novartis, Nestle, and AstraZeneca provide European pharmaceutical and consumer staples exposure. The mix is considerably more diversified by country and sector than any of the US-focused halal funds, spanning roughly 42 countries as of the index's most recent reconstitution.
Screening methodology
SPWO uses the same S&P Shariah business-activity and financial-ratio screening framework applied globally, adapted to the accounting and disclosure standards of each constituent country. As with SPTE, non-US financial reporting introduces some lag and complexity: companies in different jurisdictions report under different accounting frameworks (IFRS in most of Europe and much of Asia, versus US GAAP), and disclosure timing varies by country, which affects how quickly the index provider can confirm ongoing compliance. ShariaPortfolio certifies the fund and publishes Shariah documentation on the SP Funds website. International Shariah screening also has to account for country-specific business norms; for example gambling and alcohol regulations vary significantly by jurisdiction, and the screen applies a consistent global standard regardless of local legality. Investors should understand that emerging-market Shariah screening in particular can be less standardized across index providers than developed-market screening, since fewer emerging-market companies have the disclosure depth of a US or European large-cap.
Costs and performance context
At 0.55%, SPWO costs meaningfully more than conventional international index funds, which often charge 0.05% to 0.15%, reflecting both the Shariah screening premium and the added complexity of screening a 42-country universe. Since its December 2023 launch, SPWO's performance has been shaped heavily by its semiconductor overweight (Taiwan Semiconductor alone is nearly a fifth of the fund) and by broader emerging-market sentiment, given the roughly 50% allocation to emerging markets. This makes SPWO more volatile and more currency-sensitive than a US-only fund like SPUS: currency movements in the Taiwan dollar, Korean won, Swiss franc, and other constituent currencies directly affect USD-denominated returns. The 30-day SEC yield of roughly 0.71% is higher than SPUS or SPTE but lower than SPRE, reflecting a mix of growth-oriented Asian technology names and more traditionally dividend-paying European pharmaceutical and consumer names.
Who it suits
SPWO suits investors who hold SPUS or HLAL for US exposure and recognize they have no non-US allocation at all, which is a meaningful diversification gap given that the US represents a shrinking share of global market capitalization over time. It is particularly relevant for investors who want exposure to the concentration of Shariah-compliant semiconductor manufacturing in Taiwan and South Korea. Investors uncomfortable with emerging-market volatility, currency risk, or a nearly 20% single-stock concentration in Taiwan Semiconductor should size this as a modest satellite position rather than a large core allocation. As with SPTE, SPWO is best used to complement, not replace, a US-focused halal core holding.
Top holdings
Purification approach
SPWO's purification figures are calculated by ShariaPortfolio and published on the SP Funds website quarterly, following the same roughly 2.5-month lag after quarter close used across the SP Funds lineup, extended in practice for SPWO given the added time needed to reconcile financial disclosures from companies reporting under IFRS and various national accounting standards across 42 countries. The impermissible income in SPWO's holdings is a mix of interest income on cash reserves, similar to the US funds, and in some cases country-specific considerations where a constituent may have a small non-compliant revenue stream that falls under the standard tolerance threshold. Because SPWO spans both developed and emerging markets, and because international disclosure standards are less uniform than US GAAP filings, investors should treat the published purification percentage as SP Funds' best aggregated estimate based on available public disclosures for each holding, rather than a figure with the same precision as a fund composed entirely of US-listed companies with SEC filing requirements. As with the other SP Funds ETFs, investors should check the current published figure on sp-funds.com before calculating a purification obligation on SPWO dividends received, rather than relying on memory of a prior quarter's number.
Frequently asked questions
Does SPWO pay dividends?
Yes, SPWO pays a monthly dividend with a 30-day SEC yield around 0.71%, higher than SPUS or SPTE due to a mix of dividend-paying European pharmaceutical and consumer names alongside growth-oriented Asian technology holdings. A purification amount typically applies and is published quarterly on the SP Funds website.
Is SPWO a US or international fund?
SPWO is a US-listed ETF, but its holdings are entirely non-US: it tracks the S&P DM Ex-U.S. & EM 50/50 Shariah Index, giving investors exposure to roughly 500 companies across 42 countries in developed and emerging markets outside the United States.
Why is Taiwan Semiconductor such a large position in SPWO?
Taiwan Semiconductor Manufacturing Company is one of the largest companies in the non-US Shariah-compliant universe and the world's largest contract chipmaker. Its size, low debt levels, and business model, manufacturing rather than lending or holding interest-bearing assets, make it a natural fit for Shariah screening and a large weighting in any global Shariah index that includes Asian markets.
Should I own SPWO alongside SPUS?
Many investors do, since SPUS provides US large-cap exposure while SPWO fills in developed and emerging international markets that SPUS entirely excludes. Together they approximate a globally diversified halal equity allocation, though investors should still size SPWO as a smaller allocation given its higher volatility and single-stock concentration in Taiwan Semiconductor.
Continue exploring
Disclaimer: PureInvest provides screening and informational tools based on established Shariah standards. It is not a financial advisor and does not provide financial, legal, or tax advice. All investment decisions should be made with the consultation of a qualified Shariah advisor and financial professional. Fund facts such as expense ratio, AUM, and holdings are researched from issuer fact sheets and may change; always confirm current figures with the fund issuer before investing.